Feed BBLR
Summary
17 / 100 · Bulios Score
Valuation 0Growth 0Profitability 0Quality 57Debt 15Stability 30
What speaks for it
- It earns 65 USD a year on every 100 USD of invested capital.
What to watch
- Revenue fell by 71% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
- Operating profit covers the interest on its debt only 2.1 times.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
20212022202320242025
Diluted EPS (USD)
20212022202320242025
Revenue fell by 71% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $1.20M.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $335.0
Debt $651.1K
Free cash flow over 12 months -$403.3K
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- North America 91%
- Europe 9.2%
North America brings in 91% of revenue.
Segments in detail